Inactive Instrument

Analyst Reco. MORPHOSYS Swiss Exchange

Equities

Real-time Estimate Tradegate Other stock markets 08:15:36 16/05/2024 BST			5-day change	1st Jan Change
67.65 ^EUR	0.00%		0.00%	0.00%

05-06	MORPHOSYS : UBS reiterates its Neutral rating	ZD
04-30	European Equities Traded in the US as American Depositary Receipts Decline	MT

MORPHOSYS : UBS reiterates its Neutral rating	05-06	ZD
MORPHOSYS : UBS remains Neutral	04-30	ZD
Trending : Novartis Begins Tender Offer for MorphoSys Shares	04-11	DJ
MORPHOSYS : UBS sticks Neutral	02-16	ZD
Novartis' Midterm Sales Growth Prospects Limited as Patent Expirations Loom, Berenberg Says	02-14	MT
MORPHOSYS : UBS revises his opinion and turns to Neutral	02-07	ZD
MORPHOSYS : UBS remains its Buy rating	02-07	ZD
Swiss Market Index Blinks Red Amid Renewed Rate Jitters	02-06	MT
North American Morning Briefing : Rate Doubts Keep Pressure on Stocks; More Earnings in Focus	02-06	DJ
MORPHOSYS : UBS reiterates its Buy rating	02-06	ZD
European Midday Briefing : Stocks Higher But Gains Capped On Rate Doubts	02-06	DJ
MORPHOSYS : JP Morgan reaffirms its Buy rating	02-05	ZD
MORPHOSYS : UBS reiterates its Buy rating	02-05	ZD
MORPHOSYS : Deutsche Bank sticks Neutral	01-31	ZD
MORPHOSYS : JP Morgan gives a Buy rating	01-30	ZD
UBS reiterates Morphosys at 'Buy' - Target 47 euros	01-30	DP
MORPHOSYS : UBS remains its Buy rating	01-30	ZD
MORPHOSYS : UBS reiterates its Buy rating	01-29	ZD
Lower Bank Earnings, Higher Interest Rates Weigh on Exchange-Traded Funds, Equity Futures Pre-Bell Tuesday	01-16	MT
MORPHOSYS : JP Morgan reiterates its Buy rating	01-15	ZD

No results for this search